BROEDL, Uli Christian,CHERNEY, David,DAIBER, Andreas,VON EYNATTEN, Maximilian,JOHANSEN, Odd-Erik,KIM, Gabriel Woojai,MAYOUX, Eric Williams,MUENZEL, Thomas,PERKINS, Bruce A,SALSALI, Afshin,SOLEYMANLOU,
申请号：
PH12015502276
公开号：
PH12015502276B1
申请日:
2015.09.30
申请国别(地区):
PH
年份:
2016
代理人:
摘要：
The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing oxidative stress, for example in patients with type 1or type 2 diabetes, as well as to the use of such SGLT-2 inhibitors in treatment and/or prevention of cardiovascular diseases in patients, for example type 1or type 2 diabetes patients. The present invention further relates to certain SGLT-2 inhibitors for treating and/or preventing a metabolic disorder and preventing, reducing the risk of or delaying the occurrence of a cardiovascular event in patients, for example patients with type 1 or type 2 diabetes.
